The indictment accuses the Glaxo official, Lauren C. Stevens of Durham, N.C., of lying to the Food and Drug Administration in 2003, by writing letters, as associate general counsel, denying that doctors speaking at company events had promoted Wellbutrin for uses not approved by the agency. Ms. Stevens “made false statements and withheld documents she recognized as incriminating,” including slides the F.D.A. had sought during its investigation, the indictment stated.
Más...
martes, 16 de noviembre de 2010
GLAXO: Las mujeres tambien...lo hacen "off-label"
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario